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Background. Nursing homes face challenges in the coming years due to the increased number of elderly. Quality will be under
pressure, expectations of the services will rise, and clinical complexity will grow. New strategies are needed to meet this situation.
Modern clinical information systems with decision support may be part of that. Objectives. To study the impact of introducing an
electronic patient record system with decision support on the use of warfarin, neuroleptics and weighing of patients, in nursing
homes. Methods. A prevalence study was performed in seven nursing homes with 513 subjects. A before-after study with internal
controls was performed. Results. The prevalence of atrial fibrillation in the seven nursing homes was 18.8%. After intervention, the
proportion of all patients taking warfarin increased from 3.0% to 9.8% (P = 0.0086), neuroleptics decreased from 33.0% to 21.5%
(P = 0.0121), and the proportion not weighed decreased from 72.6% to 16.0% (P < 0.0001). The internal controls did not change
significantly. Conclusion. Statistics and management data can be continuously produced to monitor the quality of work processes.
The electronic health record system and its system for decision support can improve drug therapy and monitoring of treatment
policy.
1. Background
Nursing homes face challenges in the coming years due to an
increased number of elderly. Quality will be under pressure,
expectations of the services will rise, and clinical complexity
will grow. New strategies are needed to meet this situation.
Modern clinical information systems with decision support
may be part of that.
1.1. Clinical Issues. Based on clinical experience and infor-
mation about 513 long-term patients, we believed that
there could be failure of the blood-thinning treatment of
patients with atrial fibrillation. Likewise, we thought that
weighing procedures were followed up for the poor. Use
of neuroleptics for the oldest patients is under continuous
debate. Therefore, we decided to focus on endpoints within
these fields.
One of the most frequent diagnoses among the elderly
is atrial fibrillation. Atrial fibrillation is an independent risk
factor for developing a stroke [1], and in the elderly it is
one of the most important causes of stroke [2]. The current
guidelines in force are that all over-75s with atrial fibrillation
are to be anticoagulated, but increasing age often produces
the opposite eﬀect with decreased prescriptions to the oldest
[3, 4].
The presence of nutritional failure in Norwegian nursing
homes has been questioned [5]. Little research in the field has
been done so far. There is good evidence showing that inap-
propriate weight loss in the elderly materially impairs their
quality of life and life prospects. The convalescence period
for illness also increases substantially [6]. A significantly
increased risk has been shown for secondary complications
like pressure sores [7], infection, depression, and functional
impairment [8, 9] as well as increased mortality [10–14].
The high consumption of psychopharmaceuticals in
nursing homes has been emphasized in a number of
studies. 23% of the demented nursing home population in
Bergen was found to be on antipsychotics. The prevalence
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of psychoactive drugs has been well documented earlier,
but some years ago [15, 16]. Double-blind studies have
shown little symptom reduction connected with the use of
antipsychotics as compared with placebo [17, 18].
1.2. Decision Support. There are weaknesses involved in
introducing consensus-based therapeutic regimes in a pop-
ulation. Often test results are not followed up. In a meta-
analysis, Kawamoto and colleagues dealt with studies on the
eﬀectiveness of decision-making support tools and found
that 68% of the systems showed significant improvement in
practice [19].
A clinical decision support system (CDSS) is an appli-
cation that analyzes data to help healthcare providers
make clinical decisions. Decision-making support is closely
correlated with structured record information, because the
decision-making support tools have to respond to correct
information in the record—for example, pathological test
results. This is easier to accomplish if the underlying data are
structured and standardized. A number of major European
projects hinge on this issue [20].
The traditional medical approach focuses on the indi-
vidual, with particular emphasis on symptoms, signs and
test results emerging from the encounter with individual
patients. In order to ensure accessible and correct treatment
for all patients, it is also possible to operate using population-
directed control measures, for example, keeping track of
the proportion of a patient population on a specific drug.
This is especially applicable in nursing homes where about
75% of patients are demented and cannot take responsibility
for their own followup. The benefit of population-targeted
intervention has also been proved in several studies [21].
The users’ views on data systems are important for the
real-term prospects of disseminating such tools. Doctors
appreciate structured recording [22, 23]. Nurses’ views on
electronic patient records have been studied at a major
hospital in Florida [24]. Of 100 nurses, one-third felt that
electronic patient records resulted in a reduced workload and
roughly the same proportion preferred being able to provide
documentation at the patient’s bedside, but said that this was
often made diﬃcult. A quarter thought that documentation
was improved and the use of electronic patient records
would improve patient safety. Nurses with experience of
information technology consistently had more positive views
than those without such experience.
In this project, we wanted to study whether decision
support as part of an electronic, structured patient record
system, together with targeted education, could improve the
quality of medical treatment while avoiding negative impact
on job satisfaction among users.
2. Material and Methods
We performed a prevalence study to quantify the proportion
of long-term patients with atrial fibrillation that were being
given warfarin, were taking neuroleptics, and had not been
weighed for the last 30 days. Then, a before-after intervention
study was done. The before-after study was conducted as
a double cross-sectional design. Instead of randomization,
we decided to use the proportion of patients on digitalis,
thyroxin, and antidiabetics as internal controls (participants
exposed to the same study, but these drugs were not part of
any concrete intervention and were unlikely to undergo any
changes by external factors.) [25]. The proportion of patients
on neuroleptics was in addition followed as a time series
(a sequence of data points, measured typically at successive
times spaced at uniform time intervals) [26–28] in two
nursing homes from 23 October 2008 to 15 July 2010.
2.1. Before-Data. The prevalence (before) survey was per-
formed among long-term residents in seven nursing homes
(N = 513). Bergen, Norway has approximately 250,000
inhabitants and 37 nursing homes (2,300 beds). The number
of beds ranges from 20 to 189.
Information about the patients was gathered during the
period March-April 2008. Medical students conducted the
data collection, which consisted of copyingmedication cards,
weighing by means of a local tool, but standardized clothing,
and finding previously recorded weight/date. Electrocardio-
graphy (ECG) to diagnose atrial fibrillation was performed
and a standardized set of blood samples analysed at the
laboratory of the Bethany Hospital. The recorded data were
keyed into Excel and the drugs coded according to the
Anatomic Therapeutic Chemical (ATC) Drug Register.
The nursing homes were selected based on approximately
similar size, function, and public ownership. They were
comparable in terms of nursing staﬀ and financing, but some
diﬀerences existed with regard to other variables (Table 1).
2.2. Intervention. After quantifying clinical issues through
the before-survey, we installed an electronic, structured
patient record system which included decision support. The
system had been developed and operating at Løva˚sen edu-
cational nursing home (developing institution) for several
years, funded by the Norwegian Medical Association and the
Norwegian Research Council. Installation and training were
carried out in the last quarter of 2008, and 6 of the 7 nursing
homes were running the system on a daily basis from January
2009 for 12 months. After the active intervention period, the
number of nursing homes running the system was reduced
to three institutions, owing to contracts between Bergen
Municipality and another vendor having been signed before
the project started. Løva˚sen Nursing Home and two of the
study institutions continued and were the only institutions
available for follow-up data. Data had to be collected directly
from the electronic patient record system.
The technical intervention consisted of population filters
and reminders. The system incorporated filters and alarms
within several areas, but we decided to test 4 filters and
2 reminders. Population filters were predefined filters that
produced lists of patients according to criteria in seconds.
The tested population filters were (a) “patients taking
neuroleptics” (list and proportion), (b) “patients taking
warfarin” (list and proportion), (c) “patients with the
diagnosis atrial fibrillation and their treatment status” (list
and proportion), and (d) “patients not weighed for last 30
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Table 1: Characteristics of the 7 nursing homes in the city of Bergen, Norway, participating (N = 513 long-term patients).
Nursing home A B C D E F G Total P
N: 83 77 39 85 82 101 46 513
No. of places, total/long/short 108/88/20 84/63/21 66/31/35 90/90/0 107/81/26 131/99/32 64/48/16 650/500/150
Location in city Suburb Inner city Suburb Suburb Inner city Suburb Suburb
Doctors’ hours per place per week 0.4 0.3 0.5 0.3 0.4 0.4 0.5 0.4
Men, % 33.7 33.8 28.2 26.7 21.0 37.6 30.4 30.2 0.2731
Age, years
Mean 86.7 85.2 84.7 84.9 88.2 79.6 82.2 84.4 <0.0012
Standard deviation 7.6 10.7 7.5 9.1 6.8 15.7 10.0
Length of stay, days
Mean 990.0 901.5 973.1 946.1 1,728.9 1,383.1 1,055.2 1,171.5 <0.0012
Standard deviation 1102.9 1038.9 747.8 849.6 1075.2 1299.9 873.43
Nondemented n = 511, % 20.7 31.6 0.0 29.4 41.5 20.8 19.6 23.4 <0.0011
Deviation % −2.7 8.2 −23.4 6.0 18.1 −2.6 −3.8
Suﬀered stroke n = 462, % 32.4 10.2 28.2 35.4 21.5 30.0 15.4 24.7 0.0091
Deviation % 7.7 −14.5 3.5 10.7 −3.2 5.3 −9.3
1
Pearson’ chi-square test; 2Kruskal-Wallis test.
Table 2: User survey among employees in 7 nursing homes in
Bergen (N = 272, 54%).
Sex % Age % Position N %
Male 12 <40 34 Nurse 97 37
Female 88 40–54 46 Assistant nurse 91 35
>54 20 Physician 16 6
Other 58 22
days” (list and proportion). Tested reminders visible in each
patient’s record, if the criteria were met, were (a) “patient
has diagnosis of atrial fibrillation but is not on warfarin” and
(b) “patient not weighed for last 30 days.” Figures 1 and 2
demonstrate how this was arranged within the application.
Results from the before-study were presented to the par-
ticipating doctors during the first 12 months of intervention
through three two-hour lectures.
2.3. After-Data. Two institutions (E and F in Table 1)
participated in the after-study. To collect the data we used
the population filters in the medical record system to find the
proportions of patients on endpoint drugs, internal controls,
and patients not weighed for the last 30 days. Before-data
were extracted from the prevalence study for institutions E
and F (N = 183) for the before-after analysis. Institution E
participated with an additional department (22 patients) in
the intervention study (N = 205, after).
To study user satisfaction, we performed an anonymous
survey among the doctors, nurses, assistant nurses, and
physiotherapists (N = 504). Potential respondents were all
users defined in the electronic system. They were invited by e-
mail to respond to an electronic questionnaire. 16 questions
about position and several aspects of their view on the
functionality of the application were presented. Questions
were closed, with a score from 1 to 5 (worse–better). The
Table 3: Results from the user survey among employees in 8
nursing homes in Bergen, Norway, participating testing the “UNO
GBD” electronic patient record system (2008–2010), a structured
medical record system with decision-making support (N = 272,
54%).
(i) 65%—used application on a daily basis
(ii) 81%—exploited reminders when planned the work
(iii) 90%—documentation requirements were met
(iv) 67%—less time consuming
(v) 43%—increased job satisfaction
(vi) 72%—reminders supported them in doing the job
(vii) 83%—application contributed to safer medication
survey was constructed by a group of study nurses from the
institutions, with technical organization by the vendor.
2.4. Statistics. For the prevalence (before) survey, the
recorded data were keyed into an Excel worksheet and
the drugs coded according to the Anatomical Therapeutic
Chemical (ATC) Drug Register. To compare proportion of
populations, Pearson’s chi-square test was used. To com-
pare distribution of continuous variables, Kruskal-Wallis’
nonparametric one-way analysis of variance was performed.
Straight counts were performed in Excel, but JMP 8 was
generally used for statistical analyses.
3. Results
In the prevalence study, all long-term patients in 7 nursing
homes were examined (N = 513). There were no dropouts.
The before-after study included all long-term patients in two
institutions (N = 183 before, 205 after), also no drop-outs.
272 (54%) users responded to the questionnaire, Tables 2 and
3.
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Figure 1: Population filters. How subgroup filters and reports are presented in the UNO GBD patient record system, a structured medical
record system with decision-making support, tested in 7 nursing homes in Bergen, Norway 2008–2010. The blue “menu” is for translation
purposes.
3.1. Before-Survey. In the prevalence study of 484 long-term
patients ECG-ed, atrial fibrillation was found in 91 (18.8%).
No significant diﬀerences existed between the 7 institutions.
Of 91 atrial fibrillation patients, 14.2% were anticoagulated
with warfarin, that is, 2.5% of all patients.
72.6% of all patients were not weighed for the last 30
days. There was an average of 121 days between weight
measurements. Significant diﬀerences were demonstrated
between nursing homes.
Of all patients, 24.4% were taking neuroleptics. 30.0% of
the patients taking neuroleptics were onmore than one drug.
3.2. Before—After. At the two institutions (E and F) partic-
ipating in the before-after study, the proportion of patients
taking neuroleptics was reduced from 33.0% to 21.5% (N =
183 before/205 after, chi-square test, P = 0.015), that is,
a diﬀerence of 11.5% (95% CI: 2.3 to 20.6%). Warfarin
increased from 3.0% to 9.8% (P = 0.013), that is, a diﬀerence
of 6.8% (95% CI: 1.6 to 12.1%). Use of digitoxin did not
increase significantly (8.0% versus 8.5%; P = 0.1), thyroxin
was not reduced (10.0% versus 8.6%, P = 0.765), and
antidiabetics did not increase (10.0% versus 10.5%; P =
0.996), Figure 4. The proportion of patients not weighed for
the last 30 days was reduced from 72.6% to 16.0% (P <
0.001), that is, a diﬀerence of 56.6% (95% (CI: 47.5 to
64.5%).
The time-series for proportions of patients using neu-
roleptics is presented in Figure 3.
In the user survey (n = 272, 54%), 43% reported great or
slightly better job satisfaction. Further results from the user
survey are presented in Table 3.
4. Discussion
Endpoints changed significantly during intervention by
increased use of warfarin, decreased use of neuroleptics, and
a higher weighing rate. Job satisfaction was not adversely
aﬀected.
4.1. Limitations of the Study. The role of nursing homes
in the delivery of social and health care services diﬀers
between, as well as within, countries. Nursing homes inmany
countries are managed as part of social care. In Norway,
nursing homes are regulated as a health care service. These
ISRN Nursing 5
Figure 2: The way “reminders” and interaction warnings are presented in UNO GBD, a structured medical record system with decision-
making support, tested in 7 nursing homes in Bergen, Norway 2008–2010. The grey “menu” is for translation purposes.
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Figure 3: Time-series on the proportion of patients using neu-
roleptics, in 3 nursing homes in Bergen, Norway 2008–2010,
before and during implementation with a structuredmedical record
system with decision support. Blue line represents institution E
(see Figure 1), green line institution F, and red line the developing
institution. Institution E and F were included in the before-after
study. Red arrow indicates implementation startup.
diﬀerences may influence the health issue landscape and
composition of staﬀ. Thus, comparisons and generalizations
based on our findings should be made with care.
The methods for evaluating change and improvement
strategies are not well described. Such study designs should
generally be used in a context where they build on appropri-
ate theoretical, qualitative, and modelling work, particularly
in the development of appropriate interventions [29]. We
feel that we have properly documented the fields in need of
improvement and thus study objectives.
Baseline and follow-up data for the first cross-sectional
sample were collected, by the prevalence study (before) and
(in the case of the second sample) after the intervention,
respectively. As it was not possible to collect follow-up data
for everyone included in the first study (for political reasons)
and the patients included in the second sample were not
identical to those in the first due to deaths, the two samples
were compared using methods for comparing unpaired data.
This is a weakness, but to compensate for the 40% or so
annual death rate in nursing homes, the sample size would
have had to be much higher to be able to use patients as their
own controls, and this may not have been advisable when
testing front-end technology in the first study.
Our design must be seen in light of the immaturity
of research in nursing homes in general. As far as we
know, neither recent data exist on the prevalence of atrial
fibrillation in a nursing home population and the use of
warfarin, nor is information available on how well basic
procedures like weighing are conducted. More information
has been available on the use of neuroleptics. There was
therefore a need to do a prevalence study, to define valid
endpoints, and to do an intervention study. It may be
claimed that we should have separated the tasks, but nursing
homes are in great need of improvement strategies and
time is short before the elderly wave is set to impact
6 ISRN Nursing
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Figure 4: Changes in endpoints and internal controls in the before-
after intervention study, among long-term patients in 2 nursing
homes in Bergen, 2008–2010. Before and after intervention with
a structured medical record with decision-making support, the
proportion of patients on the drugs was measured (N = 182
before/205 after, chi-square test) Dark blue = Neuroleptics, red =
warfarin, others = internal controls.
heavily on nursing home demands. Financial and political
limitations played a role too, obstructing any possibility
of performing a full-scale follow-up study. But conversely,
it would have been a challenge, in a randomized trial
within one municipality, albeit with 37 institutions to choose
from, to avoid study group pollution and the “Hawthorne
eﬀect” [29, 30]. Starting out with a comprehensive and
expensive randomized study would probably not have been
ethical due to all the uncertainty and possible threats from
new information technology systems, and hence probably
diﬃcult to fund. When we started, we did not know if it was
possible to install the application, educate, and prepare for
critical daily use in 7 institutions with 500 to 800 users within
a timeframe of 4months. Looking back, this may be regarded
as the most convincing result of the project.
4.2. Eﬀects of Integrated Electronic Decision Support. We used
a design where we evaluated endpoints in a before-after
study with internal controls [26–28]. The stability of internal
controls throughout the intervention reinforces the internal
validity of the study.
With the technology presented, eﬀects can be measured
continuously, Figure 3. However, we cannot conclude the
extent to which the technical aspect or “awareness of the
performance process” is responsible, through education, for
the changes measured. Yet without any performance figures,
it is not possible to focus on changing processes, so the two
ways of influencing results are not independent factors.
The technology made it possible to monitor performance
without time-consuming traditional studies and made per-
formance feedback possible. This is a relatively new concept
in medical research, made possible by structured medical
input applicable to automatic and continuous analysis.
Consequently, the proportion of patients taking neuroleptics
could also be followed using time-series, givingmore detailed
information about the changing process and strengthening
the validity of the eﬀect results. As a critical information
element, drugs were punched into each patient record at an
early stage of the implementation process and this gave us
a suﬃcient “before-point” on the time-series. We discovered
that the significant change in the before-after study was due
to only one of the participating institutions and that this
institution showed up a clear brake in the curve at the point
of intervention startup.
4.3. New Possibilities. We see from the time-series on neu-
roleptics (time-series are part of the patient record system)
that the tool also provides a deeper understanding of the
change process. By observing the curves, Figure 3, we learn
something about possible variation in the use of neuroleptics
during the year. This makes one think that performance
feedback, over time, may equal performance around a “total
average” [31]. Other authors have concluded that evaluative
studies should report on usage patterns and progression of
outcomes over time [32]. Very few authors have reported
on feedback at institutional level with performance com-
parisons. At vaccination clinics, however, it has been shown
that performance feedback at institutional level can improve
quality [33]. Logically, this may be one way of influencing
both generalized over- and undertreatment in institutions.
Our own research (same material, and publications to come)
has shown that diﬀerences between comparable nursing
homes do exist, significantly. With regard to both the
proportion of patients using cardiovascular and psychoactive
medications, and weight loss and weighing routines, we
found significant diﬀerences between the 7 nursing homes
participating in the prevalence survey (same study, diﬀerent
publications). We hope to continue our research based on
this feedback method to test if this is a way to increase
equality and quality among a bigger number of institutions.
We are however convinced of the importance of human
attention. Technology is a tool only, without any impact, if
managers and practitioners are not reacting to warnings and
are not exploiting the population filter function!
5. Conclusions
Statistics and management data can be continuously pro-
duced through daily bedside work. The structured electronic
patient record system with decision support we tested
can improve drug treatment and monitoring and better
implementation of procedures. It can easily be installed
for use in nursing homes. Controlled studies on a broader
spectrum of clinical and administrative parameters should
be performed.
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